Blade Q4 revenue $38.1M (+55% YoY); FY revenue $146.1M (+118%)

Strata Critical Medical, Inc.

Q4 revenue $38.1M, up 55% YoY; FY revenue $146.1M, up 118% YoY.
Short Distance revenue up 51% in Q4; MediMobility Organ Transport revenue up 120% in Q4.
Flight Profit increased 38% in Q4, driven by organic and inorganic growth.
Completed first piloted EVA test flight in NYC with BETA Technologies.
Management expects cash balance available for acquisitions; path to profitability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.